Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

IO Biotech Inc

IOBT
Current price
0.97 USD +0.001 USD (+0.10%)
Last closed 0.93 USD
ISIN US4497781090
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 72 468 992 USD
Yield for 12 month +2.12 %
1Y
3Y
5Y
10Y
15Y
IOBT
21.11.2021 - 28.11.2021

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive mechanisms mediated by Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark. Address: Ole Maaløes Vej 3, Copenhagen, Denmark, 2200

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8.2 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-756 000 USD

Last Year

-540 000 USD

Current Quarter

-214 000 USD

Last Quarter

-211 000 USD

Key Figures IOBT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -93 157 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -50.98 %
PEG Ratio
Return On Equity TTM -87.66 %
Wall Street Target Price 8.2 USD
Revenue TTM
Book Value 1.46 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.26 USD
Diluted Eps TTM -1.26 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics IOBT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IOBT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation IOBT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 1.3637
Price Book MRQ 0.7528

Financials IOBT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IOBT

For 52 weeks

0.73 USD 2.1 USD
50 Day MA 1.1 USD
Shares Short Prior Month 317 530
200 Day MA 1.38 USD
Short Ratio 0.38
Shares Short 277 050
Short Percent 1.15 %